Unichem Pharmaceuticals USA Inc. FDA Inspection Record

FEI 3015297395 · Inspections, Form 483s, warning letters and import refusals

Unichem Pharmaceuticals USA Inc. is an FDA-inspected facility (FEI 3015297395) located in East Brunswick, NJ, US. RegDataLab tracks 1 FDA inspection at this facility.

What FDA found at this site

Latest inspection
Sep 21, 2023: No Action Indicated (NAI)
Inspections on record
1 (1 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
9, latest Oct 30, 2026
Import refusals
1

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Sep 21, 2023No Action Indicated (NAI)No citations listed

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Oct 30, 2026Class IID-0183-2027Amiodarone Hydrochloride Tablets, USP, 200 mg, 60 Tablets per bottle, Rx Only…
Presence of Foreign Substance
Apr 13, 2026Class IIID-0511-2026busPIRone Hydrochloride Tablets, USP, 5 mg, 500-count bottle, Rx Only, Manufactured by…
Subpotent drug
Jan 21, 2026Class IID-0301-2026Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count…
cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.
Jan 21, 2026Class IIID-0306-2026Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem…
Tablets/Capsules Imprinted with Wrong ID
Aug 27, 2025Class ID-0655-2025Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, 90-count bottle, RX only…
Labeling: Label Mix Up; Bottles of Meloxicam USP, 7.5mg, 90-count tablets (yellow in color), were labeled as Cyclobenzaprine Hydrochloride…
Sep 19, 2022Class IIID-1541-2022Clonidine Hydrochloride Tablets, USP, 0.3 mg, 100-count bottle, Rx Only, Manufactured by…
Product mix-up:0.2 mg strength Clonidine Hydrochloride Tablets, USP in a 100-count bottle of 0.3 mg strength Clonidine Hydrochloride…
Oct 25, 2021Class IIID-0255-2022Topiramate Tablets, USP 50 mg, 500-count bottles, Rx Only, Manufactured by: Unichem…
Discoloration
May 26, 2020Class IIID-1291-2020Clonidine Hydrochloride Tablets, USP 0.1 mg 100-count bottles, Rx only, Manufactured by…
Failed Impurities/Degradation Specifications: potential migration of benzophenone at very low level into the product from container.
Jan 29, 2020Class IIID-0829-2020Clonidine Hydrochloride Tablets, USP 0.1mg, Rx Only, 100-count bottle, Manufactured by…
Failed Impurities/Degredation Specifications: This recall is initiated as a precautionary measure due to potential migration of Benzophenone…

FDA record score

23 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 16, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

3 records behind this number
RecordDatePoints x age weightAdds
Class I recall D-0655-2025, this FEI as the recalling firmAug 27, 202515 x 115
Class II recall D-0183-2027, this FEI as the recalling firmOct 30, 20264 x 14
Class II recall D-0301-2026, this FEI as the recalling firmJan 21, 20264 x 14

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Unichem Pharmaceuticals USA Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Unichem Pharmaceuticals USA Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Unichem Pharmaceuticals USA Inc.
Location
East Brunswick, NJ (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.